by | PRNewswire Asia
TAINAN, Feb. 10, 2026 /PRNewswire/ — MerryLife Biomedical Inc., a clinical-stage biotechnology company focused on neurodegenerative diseases, today announced positive Phase 1 results for TML-6, its investigational oral therapy for Alzheimer’s disease (AD)....
by | PRNewswire Asia
Collaboration with impact – Turning partnerships into regional innovation for Singapore’s next phase of growth Innovating for tomorrow – Developing next-gen adhesive solutions that meet future industry needs Building sustainable progress – Advancing circular...
by | PRNewswire Asia
BANGKOK, Feb. 10, 2026 /PRNewswire/ — Researchers at Chulalongkorn University are redefining the role of Thai silk by developing silk protein into a versatile platform for medical products, aiming to reduce Thailand’s reliance on imported biomaterials...
by | PRNewswire Asia
The brand also expands daily disposable options for astigmatic adults with the launch of ACUVUE® OASYS MAX 1-Day for ASTIGMATISM, bringing pioneering innovation that delivers visual clarity and comfort [+],[**],[2],[3] as vision needs evolve. SINGAPORE, Feb....
by | PRNewswire Asia
HONG KONG, Feb. 9, 2026 /PRNewswire/ — AIA Group Limited ("AIA" or the "Group") today releases new research revealing that deeply entrenched physical, mental and financial health stereotypes shape attitudes and behaviours around wellbeing...
by | PRNewswire Asia
HONG KONG, Feb. 9, 2026 /PRNewswire/ — Peijia Medical Limited (HKEX: 9996) today announced that it has formally submitted the European Union Medical Device Regulation (EU MDR) CE Mark registration application for its internally developed GeminiOne Transcatheter...
